ScholarLens Back to search
2008•Open Repository and Bibliography (University of Liège)Requires access

Effect of zoledronic acid (single 5 mg infusion) on lumbar spine bone mineral density versus oral risedronate (5 mg/day) over one year in subgroups of patients receiving glucocorticoid therapy

Christian Hubert Roux, Donald Malcolm Reid, J.-P. Devogelaer, K. Saag, Chak Sing Lau, Jean‐Yves Reginster, P. Papanastasiou, A. Ferreira, Florian Hartl, T. Fashola, Peter G Mesenbrink, Philip N. Sambrook

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Zoledronic acid, Bone mineral, Lumbar spine, Glucocorticoid, Osteoporosis, Bone Density Conservation Agents, Orthopedic surgery

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Effect of zoledronic acid (single 5 mg infusion) on lumbar spine bone mineral density versus oral risedronate (5 mg/day) over one year in subgroups of patients receiving glucocorticoid therapy — Research Paper | ScholarLens